Apotheke Bocken SRL

1.0 FTE

Apotheke Bocken reported revenue of 0 € for the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026), with 1 full-time equivalent.

Company number (CBE) 0801.615.522 · VAT BE0801615522
4700 Eupen
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 10 May 2023 (≈ 3 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheke Bocken shows with a free account.

See the score
Profile
SRL Micro · 1.0 FTE since 2023
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue0 €
Net result31,728 €
Equity91,219 €
Cash34,897 €
EBITDA120,834 €
Total assets426,403 €
Headcount (avg FTE)1.0
Solvency21.4%
The line marks its sector median: 41.5% (1048 companies).

Accounts of the company itself (not consolidated).

The full file covers 2 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheke Bocken's annual accounts

20252024
Revenue0 €
Net result31,728 €
Equity91,219 €
Cash34,897 €
EBITDA120,834 €
Total assets426,403 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 09 Jul 2026
  • Year ended 31 Dec 2024filed on 28 Aug 2025

Apotheke Bocken's financial analysis

Management and control of Apotheke Bocken

1 active director(s) in the register.

Apotheke Bocken's shareholders and holdings →

Apotheke Bocken's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0801.615.522
VAT number
BE0801615522
Peppol
Registered · 0208:0801615522 · as of 10 Nov 2026
Legal form
SRL
Incorporated
10 May 2023
Registered office
4700 Eupen
Size
Micro · 1.0 FTE
Latest accounts
2025 · filed on 09 Jul 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheke Bocken (SRL) has been based in Eupen since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports revenue of 0 €, a net profit of 31,728 € and equity of 91,219 €. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 21.4%, below the median of its sector (41.5%).

Companies similar to Apotheke Bocken

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheke Bocken

What is the revenue of Apotheke Bocken?

According to the 2025 annual accounts filed with the NBB, the revenue of Apotheke Bocken amounts to 0 €.

What is the VAT number of Apotheke Bocken?

In Belgium, the VAT number is the company number prefixed with BE: BE0801615522 for Apotheke Bocken, if the company is VAT-registered. Its company number (CBE) is 0801.615.522.

Where is the registered office of Apotheke Bocken?

According to the CBE register, the registered office of Apotheke Bocken is in 4700 Eupen.

What is the equity of Apotheke Bocken?

At the close of the 2025 financial year, the equity of Apotheke Bocken amounts to 91,219 €, a solvency of 21.4% of total assets.

How many people work at Apotheke Bocken?

1.0 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Apotheke Bocken?

The register lists 1 active mandates at Apotheke Bocken. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheke Bocken

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 09 Aug 2026

No credit card, no commitment.

What each plan unlocks →